GlassScriptPhysician profile
William H Boykin
NPI 1922077460
$5,327.99
in general payments reported to CMS, 2019-2025
28 companies · $1,408 in 2025
The $1,408 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,549 · 2020: $521 · 2021: $379 · 2022: $653 · 2023: $348 · 2024: $472 · 2025: $1,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485 · Travel and Lodging: $742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.03 |
| Travel and Lodging | $741.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,355.07 | 2019-2025 | |
| Astellas Pharma US INC | $754.31 | 2019-2025 | Xtandi |
| Medtronic USA, INC. | $729.43 | 2019-2020 | |
| Pfizer INC. | $476.44 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $267.07 | 2019-2024 | Xiaflex |
| Janssen Biotech, INC. | $205.91 | 2019-2024 | Erleada |
| Myriad Genetic Laboratories, INC. | $178.83 | 2021-2024 | Prolaris |
| Sumitomo Pharma America, INC. | $123.84 | 2025 | Gemtesa |
| Abbvie INC. | $114.27 | 2019-2022 | |
| Endo USA, INC. | $112.46 | 2024-2025 | Xiaflex |
| Neotract INC. | $109.61 | 2019-2020 | |
| Boston Scientific Corporation | $107.34 | 2019-2025 | Ams 700 |
| Ethicon US, LLC | $100.96 | 2022-2025 | Ethicon, Echelon; Endopath, Harmonic |
| Procept Biorobotics Corporation | $95.80 | 2022-2023 | Aquabeam Robotic System |
| Antares Pharma, INC. | $88.64 | 2020-2025 | Xyosted |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $83.42 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $74.33 | 2021-2022 | |
| Axonics, INC. | $69.75 | 2020-2023 | Axonics |
| Halozyme INC | $59.33 | 2023 | |
| Myovant Sciences INC. | $35.83 | 2021 | |
| Coloplast Corp | $33.97 | 2020-2024 | |
| Convatec INC. | $32.96 | 2022 | |
| Urovant Sciences INC | $30.76 | 2021-2022 | |
| Conmed Corporation | $20.22 | 2021 | |
| Medtronic, INC. | $19.82 | 2024 | Interstim |
| Teleflex LLC | $18.03 | 2023 | Urolift |
| Accord Healthcare, INC. | $15.11 | 2024 | |
| Olympus America INC. | $14.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Boykin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.